Home › Funds › Nantahala Capital Management, LLC › AMRX

Nantahala Capital Management, LLC position in AMRX

AMNEAL PHARMACEUTICALS INC · Health Care

Nantahala Capital Management, LLC reported holding 2,115,749 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$42.6M, representing 1.96% of its reported portfolio and ranking #9 among its reported holdings. Nantahala Capital Management, LLC has disclosed AMRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.12M sh
Reported value held$42.61M
Portfolio Weight1.96%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's AMRX position evolved

Nantahala Capital Management, LLC first disclosed a stake in AMRX in Q3 2023 at 2,212,757 shares (US$9.3M). The position peaked in Q3 2026 at 2,115,749 shares, worth US$42.6M. Across 13 filings, Nantahala Capital Management, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,115,749 shares valued at US$42.6M — a reduction of -153,002 shares quarter over quarter.. Notable position changes include a 37% increase in Q4 2024 (shares rose 6% over the following quarter), a 42% trim in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.21M $9.34M New
Q4 2023 2.33M $14.17M Add
Q1 2024 2.62M $15.88M Add
Q2 2024 2.67M $16.95M Add
Q3 2024 2.67M $22.21M Hold
Q4 2024 3.67M $29.03M Add
Q1 2025 3.81M $31.92M Add
Q2 2025 4.37M $35.33M Add
Q3 2025 4.22M $42.29M Reduce
Q4 2025 2.45M $30.84M Reduce
Q1 2026 2.84M $35.35M Add
Q2 2026 2.27M $39.27M Reduce
Q3 2026 2.12M $42.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMRX and 13F data

AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Westshore Wealth, LLC (US$23.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMRX

All AMRX fund holders →

FAQ

How long has Nantahala Capital Management, LLC held AMRX?

Nantahala Capital Management, LLC has disclosed AMRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nantahala Capital Management, LLC's current position in AMRX?

As of Q3 2026, Nantahala Capital Management, LLC holds 2.12M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $42.61M, representing 1.96% of its reported portfolio and ranking #9.

Has Nantahala Capital Management, LLC been buying or selling AMRX?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC reduced its position in AMRX. The position peaked in Q3 2026 at 2.12M shares.

Which other funds hold AMRX?

Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Westshore Wealth, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.